- Home
- PRGO vs KLTOW Comparison
PRGO vs KLTOW Comparison
Compare PRGO & KLTOW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PRGO | KLTOW |
|---|---|---|
| Founded | 1887 | N/A |
| Country | Ireland | United States |
| Employees | N/A | 3 |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | N/A |
| IPO Year | 1991 | 2022 |
Fundamental Metrics
Financial Performance| Metric | PRGO | KLTOW |
|---|---|---|
| Price | $13.82 | $0.11 |
| Analyst Decision | Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $22.00 | N/A |
| AVG Volume (30 Days) | ★ 4.6M | N/A |
| Earning Date | 11-05-2025 | N/A |
| Dividend Yield | ★ 8.44% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $4,281,800,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $12.17 | N/A |
| 52 Week High | $30.93 | N/A |
Technical Indicators
Market Signals| Indicator | PRGO | KLTOW |
|---|---|---|
| Relative Strength Index (RSI) | 47.48 | 50.43 |
| Support Level | $12.74 | $0.10 |
| Resistance Level | $13.90 | $0.15 |
| Average True Range (ATR) | 0.42 | 0.02 |
| MACD | 0.27 | 0.00 |
| Stochastic Oscillator | 95.28 | 70.60 |
Price Performance
Historical ComparisonAbout PRGO Perrigo Company plc
Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.
About KLTOW Klotho Neurosciences Inc. Warrant
Klotho Neurosciences Inc is in the development of essential medicines for the treatment of chronic diseases: Cancer, Cardiovascular, and Neurodegenerative disorders. The Company currently has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and a proprietary, patented gene therapy platform which uses a gene therapy approach to introduce a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases. Company pipeline includes KLTO 101, KLTO 202, KLTO 301.